Lineage Cell Therapeutics
LCTX
#8801
Rank
S$0.15 B
Marketcap
$0.68
Share price
0.93%
Change (1 day)
-51.64%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -S$30.27 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are S$8.71 Million. In 2023 the company made an earning of -S$33.68 Million a decrease over its 2022 earnings that were of -S$30.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$30.27 Million-10.13%
2023 -S$33.68 Million9.83%
2022 -S$30.67 Million-54.24%
2021 -S$67.01 Million86.07%
2020 -S$36.01 Million-31.97%
2019 -S$52.94 Million-5.42%
2018 -S$55.97 Million1.1%
2017 -S$55.36 Million-31.06%
2016 -S$80.29 Million-10.38%
2015 -S$89.6 Million29.69%
2014 -S$69.09 Million31.68%
2013 -S$52.47 Million
2011 -S$25.47 Million89.78%
2010 -S$13.42 Million206.06%
2009 -S$4.39 Million-0.58%
2008 -S$4.41 Million164.89%
2007 -S$1.67 Million-30.22%
2006 -S$2.39 Million
2002 -S$2.78 Million-41.04%
2001 -S$4.7 Million-32.04%
2000 -S$6.92 Million-11.85%
1999 -S$7.85 Million
1997 -S$5.04 Million12.12%
1996 -S$4.5 Million106.25%
1995 -S$2.18 Million-11.11%
1994 -S$2.46 Million50%
1993 -S$1.64 Million20%
1992 -S$1.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.19 Billion 492.84%๐Ÿ‡บ๐Ÿ‡ธ USA